Jane Street Group, LLC Vanda Pharmaceuticals Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $70,072 - $96,368	15,200 New	15,200 $71,000
Q2 2022 Aug 16, 2022	SELL	$9.31 - $11.84 $106,134 - $134,976	-11,400 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$10.84 - $16.55 $68,292 - $104,265	-6,300 Reduced 35.59%	11,400 $129,000
Q4 2021 Feb 15, 2022	BUY	$15.69 - $21.14 $106,692 - $143,752	6,800 Added 62.39%	17,700 $278,000
Q3 2021 Nov 16, 2021	SELL	$15.35 - $21.27 $208,760 - $289,272	-13,600 Reduced 55.51%	10,900 $187,000
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $384,895 - $526,995	24,500 New	24,500 $527,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.